September 27, 2004

Vanderbilt University Medical Center Launches Genital Herpes Vaccine Trial

Vanderbilt University Medical Center researchers are launching a clinical trial of Herpavac, a new genital herpes vaccine that has proven effective in previous clinical trials in preventing the spread of the herpes simplex virus in women.

By VUMC News and Communications